AbbVie Inc - Change Receivables

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-Receivables" stands at -1.26 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2023.

AbbVie Inc's third quarter result of -0.156 Billion USD for the item "Change Receivables" represents a decrease of -817.65 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of -0.156 Billion USD for the item "Change Receivables" represents a decrease of -145.35 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of -1.26 Billion USD for the item "Change Receivables" represents a decrease of -65.36 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.42 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.42 Billion United States Dollars.
The 3 year change is 0.523 Billion United States Dollars.
The 5 year change is -0.824 Billion United States Dollars.
The 10 year change is -0.156 Billion United States Dollars.

The Serie's long term average value is -0.473 Billion United States Dollars. It's latest available value, on 09/30/2025, is -0.792 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +0.523 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2014, to it's latest available value, on 09/30/2025, is -2.06 Billion.